Trials

Placebo-controlled trial testing safety and effectiveness of Enterosgel® for treating functional belly pain in children and young people

Updated

Abstract

Functional abdominal pain disorders (FAPDs) are common in children and may significantly impact quality of life.

  • FAPDs include conditions like irritable bowel syndrome, functional dyspepsia, abdominal migraine, and unspecified functional abdominal pain.
  • These disorders can lead to reduced school attendance and participation in activities, comparable to children with inflammatory bowel disease.
  • The causes of FAPDs may involve disruptions in the microbiota-gut-brain connection.
  • Current treatments lack proven significant efficacy for FAPDs.
  • Enterosgel®, a silicon-based intestinal absorbent, is known to normalize gut microbiota and may be effective in treating FAPDs.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free